SAB Biotherapeutics, Inc. (SABS) Stock Price History
Historical prices from 2021 to 2026
Loading 10-year price history...
SABS Historical Performance
Short-Term Returns
SABS Stock Price Trajectory (2021–2026)
As of May 8, 2026, SAB Biotherapeutics, Inc. (SABS) trades at $4.09, representing a +142.0% return over the past year. The stock has delivered a -95.9% total return over five years (-47.1% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $129.00 on October 22, 2021. From this peak, SABS has corrected -96.8%, currently trading 24% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers IMVT (+96.1% 1Y), ARGX (+26.4% 1Y), and HALO (-7.1% 1Y), SABS has underperformed the peer group average. Compare SABS vs IMVT →
SABS Historical Price Data (2025–2026)
Showing 30 of 1,318 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 4.38 | 4.45 | 3.77 | 4.09 | 3.27M | +7.63% |
| 2026-05-06 | 3.73 | 3.98 | 3.63 | 3.80 | 709K | +3.26% |
| 2026-05-05 | 3.66 | 3.70 | 3.55 | 3.68 | 361K | -0.27% |
| 2026-05-04 | 3.45 | 3.79 | 3.45 | 3.69 | 667K | +6.34% |
| 2026-05-01 | 3.72 | 3.82 | 3.46 | 3.47 | 626K | -7.22% |
| 2026-04-30 | 3.49 | 3.84 | 3.49 | 3.74 | 644K | +7.47% |
| 2026-04-29 | 3.51 | 3.58 | 3.41 | 3.48 | 322K | -1.42% |
| 2026-04-28 | 3.47 | 3.55 | 3.43 | 3.53 | 233K | +1.73% |
| 2026-04-27 | 3.52 | 3.65 | 3.44 | 3.47 | 424K | -1.42% |
| 2026-04-24 | 3.71 | 3.75 | 3.51 | 3.52 | 555K | -7.37% |
| 2026-04-23 | 3.99 | 4.07 | 3.79 | 3.80 | 465K | -4.76% |
| 2026-04-22 | 3.85 | 4.01 | 3.80 | 3.99 | 442K | +4.72% |
| 2026-04-21 | 3.87 | 3.87 | 3.68 | 3.81 | 413K | -1.30% |
| 2026-04-20 | 3.85 | 3.92 | 3.75 | 3.86 | 256K | +0.26% |
| 2026-04-17 | 3.97 | 4.03 | 3.83 | 3.85 | 344K | -1.79% |
| 2026-04-16 | 4.02 | 4.05 | 3.87 | 3.92 | 308K | -3.21% |
| 2026-04-15 | 3.86 | 4.08 | 3.80 | 4.05 | 879K | +4.92% |
| 2026-04-14 | 3.95 | 3.98 | 3.83 | 3.86 | 618K | -1.03% |
| 2026-04-13 | 3.81 | 3.94 | 3.73 | 3.90 | 265K | +4.00% |
| 2026-04-10 | 3.83 | 3.84 | 3.73 | 3.75 | 194K | -2.09% |
| 2026-04-09 | 3.71 | 3.86 | 3.65 | 3.83 | 232K | +2.68% |
| 2026-04-08 | 3.83 | 3.86 | 3.69 | 3.73 | 185K | -0.80% |
| 2026-04-07 | 3.79 | 3.89 | 3.71 | 3.76 | 186K | -2.34% |
| 2026-04-06 | 3.84 | 3.90 | 3.81 | 3.85 | 249K | -0.77% |
| 2026-04-02 | 3.88 | 3.97 | 3.83 | 3.88 | 205K | +0.26% |
| 2026-04-01 | 3.84 | 3.93 | 3.84 | 3.87 | 404K | +1.04% |
| 2026-03-31 | 3.79 | 3.90 | 3.78 | 3.83 | 329K | +1.32% |
| 2026-03-30 | 3.82 | 3.86 | 3.76 | 3.78 | 443K | -1.82% |
| 2026-03-27 | 3.82 | 3.91 | 3.79 | 3.85 | 805K | +0.52% |
| 2026-03-26 | 3.82 | 3.89 | 3.79 | 3.83 | 650K | +0.26% |
See SABS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SABS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SABS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSABS — Frequently Asked Questions
Quick answers to the most common questions about buying SABS stock.
How has SABS stock performed recently?
SABS returned +142.0% over the past year, beating its 5-year annualized CAGR of -47.1%. The stock trades above its 200-day moving average, confirming the uptrend.
What is SABS's all-time high price?
SAB Biotherapeutics, Inc. reached $129.00 on 2021-10-22. The 52-week high is $6.60. Current 1-year return of +142.0% places the stock closer to historical peaks.
Where can I download SABS historical price data?
This page provides SABS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.